Efficacy and Tolerability of Ombitasvir/Paritaprevir/Ritonavir in HCV Genotype 1-infected Elderly Japanese Patients
Haruki Uojima
, Shuzo Kobayashi‡, Hisashi Hidaka†, Takeshi Kinbara*, Tomoaki Fujikawa§, Tsuyoshi Nakayama||, Hiroki Yamanoue¶,*, Takayuki Kanemaru**, Tohru Hashimotoh††, Ji Hyun Sung*, Makoto Kako*, Wasaburo Koizumi†
,†,
Corresponding author
* Department of Gastroenterology, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, Japan
† Department of Gastroenterology, Internal Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, Japan
‡ Department of Kidney Disease and Transplant Center, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura Kanagawa, Japan
§ Department of Gastroenterology, Shonan Fujisawa Tokushukai Hospital, Tsujidokandai, Fujisawa, Kanagawa, Japan
|| Department of Gastroenterology, Shonan Atsugi Hospital, 118-1 Nurumizu, Atsugi, Kanagawa, Japan
¶ Department of General Internal Medicine, Shizuoka Tokushukai Hospital, Shimokawara, Suruga, Shizuoka, Japan
** Department of Surgery, Haibara General Hospital, 2887-1, Hosoe, Makinohara, Shizuoka, Japan
†† Department of General Internal Medicine, Narita Tomisato Tokushukai Hospital, 1-1-1 Hiyoshidai, Tomisato, Chiba, Japan
Read
1602
Timeswas read the article
443
Total PDF
1159
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 10 | 4 | 14 |
| 2025 11 | 54 | 28 | 82 |
| 2025 10 | 27 | 3 | 30 |
| 2025 9 | 30 | 13 | 43 |
| 2025 8 | 35 | 14 | 49 |
| 2025 7 | 39 | 9 | 48 |
| 2025 6 | 30 | 3 | 33 |
| 2025 5 | 19 | 3 | 22 |
| 2025 4 | 17 | 6 | 23 |
| 2025 3 | 17 | 5 | 22 |
| 2025 2 | 14 | 2 | 16 |
| 2025 1 | 19 | 2 | 21 |
| 2024 12 | 9 | 3 | 12 |
| 2024 11 | 18 | 6 | 24 |
| 2024 10 | 5 | 2 | 7 |
| 2024 9 | 6 | 2 | 8 |
| 2024 8 | 9 | 0 | 9 |
| 2024 7 | 12 | 3 | 15 |
| 2024 6 | 5 | 0 | 5 |
| 2024 5 | 16 | 3 | 19 |
| 2024 4 | 8 | 0 | 8 |
| 2024 3 | 27 | 6 | 33 |
| 2024 2 | 24 | 8 | 32 |
| 2024 1 | 6 | 4 | 10 |
| 2023 12 | 5 | 2 | 7 |
| 2023 11 | 14 | 4 | 18 |
| 2023 10 | 9 | 2 | 11 |
| 2023 9 | 7 | 0 | 7 |
| 2023 8 | 9 | 2 | 11 |
| 2023 7 | 11 | 3 | 14 |
| 2023 6 | 19 | 2 | 21 |
| 2023 5 | 32 | 1 | 33 |
| 2023 4 | 40 | 1 | 41 |
| 2023 3 | 15 | 1 | 16 |
| 2023 2 | 16 | 3 | 19 |
| 2023 1 | 6 | 3 | 9 |
| 2022 12 | 8 | 2 | 10 |
| 2022 11 | 17 | 6 | 23 |
| 2022 10 | 13 | 4 | 17 |
| 2022 9 | 11 | 11 | 22 |
| 2022 8 | 9 | 9 | 18 |
| 2022 7 | 14 | 10 | 24 |
| 2022 6 | 14 | 6 | 20 |
| 2022 5 | 13 | 8 | 21 |
| 2022 4 | 31 | 9 | 40 |
| 2022 3 | 26 | 10 | 36 |
| 2022 2 | 25 | 4 | 29 |
| 2022 1 | 23 | 6 | 29 |
| 2021 12 | 7 | 8 | 15 |
| 2021 11 | 9 | 10 | 19 |
| 2021 10 | 6 | 8 | 14 |
| 2021 9 | 6 | 9 | 15 |
| 2021 8 | 12 | 5 | 17 |
| 2021 7 | 10 | 3 | 13 |
| 2021 6 | 4 | 13 | 17 |
| 2021 5 | 12 | 7 | 19 |
| 2021 4 | 43 | 8 | 51 |
| 2021 3 | 25 | 5 | 30 |
| 2021 2 | 7 | 6 | 13 |
| 2021 1 | 5 | 9 | 14 |
| 2020 12 | 9 | 12 | 21 |
| 2020 11 | 9 | 6 | 15 |
| 2020 10 | 7 | 4 | 11 |
| 2020 9 | 10 | 6 | 16 |
| 2020 8 | 17 | 8 | 25 |
| 2020 7 | 21 | 8 | 29 |
| 2020 6 | 11 | 7 | 18 |
| 2020 5 | 13 | 8 | 21 |
| 2020 4 | 5 | 6 | 11 |
| 2020 3 | 2 | 4 | 6 |
| 2020 2 | 11 | 3 | 14 |
| 2020 1 | 6 | 4 | 10 |
| 2019 12 | 7 | 7 | 14 |
| 2019 11 | 6 | 3 | 9 |
| 2019 10 | 4 | 4 | 8 |
| 2019 9 | 8 | 1 | 9 |
| 2019 8 | 1 | 2 | 3 |
| 2019 7 | 7 | 3 | 10 |
| 2019 6 | 7 | 8 | 15 |
| 2019 5 | 9 | 10 | 19 |
Show all
